Their data pointed out that CtBP and Sna may form a transcriptional complex that regulates JNK-dependent tumor invasion and cell migration in vivo [56], suggesting that CtBP may be a useful therapeutic target for human malignancies [44,57,58,59,60]. This evidence concerns the gene SNAI1 and neoplasm.